In cervical cancer, PSG1 was detected in 90% of precancerous lesions and all cancerous serum specimens, whereas it was undetectable in healthy women, which may provide clues for its carcinogenesis, immunological memory, and immunotolerance (Rodríguez-Esquivel et al., 2020). Here, PSG1 is linked to cervical cancer.